Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12Other 3Gastrointestinal 3Thoracic 2Head & Neck 2Gynecologic 2Sarcoma 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Melanoma 3134Skin Neoplasms 553Lymphoma, T-Cell, Cutaneous 543Carcinoma, Non-Small-Cell Lung 421Neoplasms 388Mycosis Fungoides 369Breast Neoplasms 364Carcinoma, Basal Cell 359Keratosis, Actinic 335Sezary Syndrome 331Lymphoma, Non-Hodgkin 312Carcinoma, Renal Cell 308Neoplasm Metastasis 304Lymphoma 299Leukemia, Lymphocytic, Chronic, B-Cell 292Lymphoma, Large B-Cell, Diffuse 287Lymphoma, Follicular 286Hodgkin Disease 275Uveal Melanoma 274Lymphoma, B-Cell, Marginal Zone 273Lymphoma, Mantle-Cell 272Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Burkitt Lymphoma 258Lymphoma, Large-Cell, Immunoblastic 248Lung Neoplasms 236Colorectal Neoplasms 232Ovarian Neoplasms 214Lymphoma, Large-Cell, Anaplastic 206Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 203Multiple Myeloma 199

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Risk Reduction Behavior × Dermatologic × Clear all
NCT03315286 2019-12-18

Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure

Weill Medical College of Cornell University

Phase NA Completed
111 enrolled 13 charts
Dermatologic

Skin Neoplasms, Health Behavior, Risk Reduction Behavior, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡